What RUO actually means
An RUO label legally means the product is intended for in vitro research — laboratory testing, biochemical research, scientific investigation. It is not intended for diagnostic use, human therapeutic use, or veterinary use. The label and the marketing must match that intent.
RUO is not a loophole. It's a real regulatory category with specific obligations: the product must be sold to researchers and laboratories (not consumers), the marketing must not describe therapeutic effects, and the labeling must be clear about non-human-use intent.
Why FDA enforcement targets RUO
FDA warning letters issued in 2025–2026 to peptide and GLP-1 sellers were almost uniformly about copy. The pattern is recognizable: a product is labeled "Research Use Only" but the website includes dosing instructions for human use, customer reviews describing weight loss or muscle gain, comparison charts against approved drugs, and a checkout flow that doesn't verify the buyer is a researcher.
The FDA reads that as the RUO label being a fig leaf — the actual intent is consumer sale, with the disclaimer protecting the seller from drug-approval requirements. They issue a warning letter, the brand has 30 days to remediate, and most don't.
What compliant RUO sellers actually look like
Genuine RUO commerce exists. The compliant version looks like:
- Customer verification — checkout requires institutional affiliation, university email, or business license
- Product page copy — describes biochemical properties, molecular weight, purity, applications in research contexts — no dosing, no clinical references
- No customer reviews describing human use (or reviews moderated to remove them)
- Wholesale pricing structure — bulk quantities for laboratory use, not consumer-friendly small bottles
- No comparison to FDA-approved drugs by name or by indication
What PeptideRails will not board
We decline RUO-only sellers whose websites read like consumer brands. The label says RUO but the marketing says weight-loss. That's the brands that get FDA-flagged, MATCH-listed, and BRAM-fined. We've seen what those portfolios do to acquirers — they sink them. So we don't board them.
If you're a genuine RUO seller serving labs and research institutions with appropriate verification, that's a different conversation. We can board that. The bar is documentation of your customer-verification process.